Company / Book Value per Share
Fulgent Genetics, Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$36.056
FY2025
5-year range
$36.056 / $41.999
FY2021-FY2025
Trend
-5.7%
vs FY2024
Sector context
#43 of 158
Health Care
What the data says
At $36.056, Fulgent Genetics, Inc.'s book value per share ranks #43 of 158 in the Health Care sector. Book Value per Share has declined for 3 consecutive years, from $41.999 in FY2022 to $36.056 in FY2025.
Based on SEC 10-K filings.
$36.056 in FY2025 with a 5-year CAGR of +6.3%.
Declined from $38.593 to $36.056 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -5.0%
- 5-Year CAGR
- +6.3%
- 10-Year CAGR
- -
Sector benchmark
#43 of 158 in Health CareTop 27% of 158This company $36.056 Sector average $48.072
▼
-25.0% below sector average
Key checks
Key Insights
- Fulgent Genetics, Inc.'s book value per share has declined for 3 consecutive years.
- 5-year CAGR of +6.3%, indicating consistent growth.
- In FY2025, book value per share decreased 5.7% year-over-year.
- Ranks #43 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 5.28 (safe zone, above 2.9 threshold)
- Negative profit margin: -15.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $36.056 | -5.7% |
| FY2024 | $38.216 | -1.0% |
| FY2023 | $38.593 | -8.1% |
| FY2022 | $41.999 | +2.1% |
| FY2021 | $41.122 | +55.2% |
| FY2020 | $26.504 | +841.6% |
| FY2019 | $2.815 | -7.3% |
| FY2018 | $3.036 | -1.0% |
| FY2017 | $3.065 | +952.8% |
| FY2016 | $0.291 | -33.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026